Status:
COMPLETED
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Hepacivirus
Eligibility:
All Genders
18+ years
Brief Summary
In February 2002, a French Consensus Conference on the management of patients with chronic hepatitis C in France was organized. The jury issued several recommendations on pegylated alpha interferon/ri...
Detailed Description
To assure a good representation of participants treated for hepatitis C, participants who meet the inclusion criteria will be enrolled on a consecutive basis.
Eligibility Criteria
Inclusion
- Adult participants starting a treatment with PegIntron for the treatment of chronic hepatitis C.
Exclusion
- Concomitant participation in a clinical trial for the treatment of hepatitis C.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
789 Patients enrolled
Trial Details
Trial ID
NCT00705666
Start Date
February 1 2006
End Date
July 1 2008
Last Update
October 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.